Compare BNTX & EME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTX | EME |
|---|---|---|
| Founded | 2008 | 1987 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Engineering & Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 27.7B |
| IPO Year | 2019 | N/A |
| Metric | BNTX | EME |
|---|---|---|
| Price | $93.95 | $622.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | $137.40 | ★ $693.60 |
| AVG Volume (30 Days) | ★ 1.3M | 406.3K |
| Earning Date | 11-03-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 0.16% |
| EPS Growth | N/A | ★ 26.22 |
| EPS | N/A | ★ 24.83 |
| Revenue | $3,698,814,972.00 | ★ $16,243,320,000.00 |
| Revenue This Year | $2.36 | $16.21 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | ★ N/A | $25.12 |
| Revenue Growth | 3.70 | ★ 14.11 |
| 52 Week Low | $81.20 | $320.89 |
| 52 Week High | $129.27 | $778.64 |
| Indicator | BNTX | EME |
|---|---|---|
| Relative Strength Index (RSI) | 36.42 | 47.99 |
| Support Level | $94.52 | $604.98 |
| Resistance Level | $97.35 | $642.20 |
| Average True Range (ATR) | 2.51 | 18.93 |
| MACD | -0.26 | 3.89 |
| Stochastic Oscillator | 3.07 | 61.82 |
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
EMCOR Group Inc is a specialty contractor in the United States and a provider of electrical and mechanical construction and facilities services, building services, and industrial services. Its services are provided to a broad range of commercial, technology, manufacturing, industrial, healthcare, utility, and institutional customers through approximately 100 operating subsidiaries. The company's operating subsidiaries are organized into reportable segments: United States mechanical construction and facilities services, which derives key revenue; United States electrical construction and facilities services; United States building services; United States industrial services; and United Kingdom building services. Geographically, its key revenue is derived from the United States.